Ameriprise Financial Inc Treace Medical Concepts, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.48 - $15.86 $8,116 - $11,213	707 Added 3.04%	23,962 $312,000
Q4 2023 Feb 14, 2024	SELL	$6.03 - $12.88 $495,539 - $1.06 Million	-82,179 Reduced 77.94%	23,255 $296,000
Q3 2023 Nov 14, 2023	SELL	$12.16 - $24.87 $879,459 - $1.8 Million	-72,324 Reduced 40.69%	105,434 $1.38 Million
Q2 2023 Aug 14, 2023	BUY	$23.91 - $27.81 $936,172 - $1.09 Million	39,154 Added 28.25%	177,758 $4.55 Million
Q1 2023 May 15, 2023	BUY	$20.23 - $26.22 $875,878 - $1.14 Million	43,296 Added 45.43%	138,604 $3.49 Million
Q4 2022 Feb 14, 2023	BUY	$20.54 - $24.67 $1.96 Million - $2.35 Million	95,308 New	95,308 $2.19 Million

137

39.7M

352K

269K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $423M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.